RECENT PLACEMENT

Occam Places Tim Trost as CFO at Werewolf

Occam Places Tim Trost as CFO at Werewolf

Werewolf Therapeutics, an MPM investment, is an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body’s immune system for the treatment of cancer.

In February 2021, Occam placed Tim Trost as CFO at Werewolf. Prior to Werewolf, Trost held numerous CFO roles at Asklepios BioPharmaceutical (AskBio), Chimerix, Argos Therapeutics, and InteCardia. He took the company public shortly after joining.

‍

Recent Placements

  1. Amber Salzman as CEO of Epic Bio
  2. Andrew Allen as Board Chair of Peptone
  3. Wes Miller as CMO of Epic Bio
  4. Allison August as CMO at Comanche Bio
  5. Danielle Belgrave, Senior DeepMind Leader as VP of AI/ML at GSK
About Occam Global

Occam Global is a trusted executive search, consulting, and investment partner for leaders and investors shaping the future of life sciences, deep tech, and venture capital. Since 2012, we’ve helped build high-performing teams and advised visionary companies from stealth to public markets. Our success stems from exceptional access to rare talent, deep sector expertise, and a commitment to results guided by elevated ethics and enlightened aggression.